PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Wednesday reported a loss of $11.6 million in its first quarter.

On a per-share basis, the Pleasanton, California-based company said it had a loss of 11 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The life science technology company posted revenue of $105.8 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $102.8 million.

10x Genomics expects full-year revenue in the range of $480 million to $500 million.

10x Genomics shares have climbed 29% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $182.90, more than doubling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG